Clincosm LogoSign in Get a demo

Management of Diverticulitis in the Emergency Department

Sponsor
Olive View-UCLA Education & Research Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT04043988
Collaborator
Centers for Disease Control and Prevention (U.S. Fed)
1,000
Enrollment
1
Location
43.5
Anticipated Duration (Months)
23
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study aims to describe current treatment practices in the US for managing acute uncomplicated diverticulitis. In addition, we will identify clinical factors associated with the decision to discharge versus hospitalize patients with uncomplicated diverticulitis with the goal of informing clinical decision-making and providing a foundation for diagnostic algorithms to guide clinical practice.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1000 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Management of Diverticulitis in the Emergency Department
    Actual Study Start Date :
    Apr 18, 2019
    Anticipated Primary Completion Date :
    May 1, 2022
    Anticipated Study Completion Date :
    Dec 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Rates of hospital admission [Day 1]

      Rates of hospital admission from the emergency department among patients being treated for acute diverticulitis will be determined. In addition, factors associated with hospital admission will be examined.

    2. Rate of Imaging [Day 1]

      The rate of imaging performed in the emergency department among patients treated for acute diverticulitis will be determined. Factors associated with imaging will also be examined.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Age ≥18 years

    • Emergency department presumptive or confirmed final diagnosis of acute diverticulitis

    • Verbal or written consent provided in English (or Spanish depending on study site)

    Exclusion Criteria:
    • None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Olive View-UCLA Medical Center Sylmar California United States 93142

    Sponsors and Collaborators

    • Olive View-UCLA Education & Research Institute
    • Centers for Disease Control and Prevention

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    David A. Talan, Principal Investigator, Olive View-UCLA Education & Research Institute
    ClinicalTrials.gov Identifier:
    NCT04043988
    Other Study ID Numbers:
    • 1396802
    First Posted:
    Aug 2, 2019
    Last Update Posted:
    Oct 12, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Diverticulitis
    Emergencies

    Study Results

    No Results Posted as of Oct 12, 2021